CAC2 Antibody is a polyclonal antibody developed against the biotin carboxylase subunit of heteromeric acetyl-coenzyme A carboxylase (ACCase) in Arabidopsis thaliana. ACCase catalyzes the ATP-dependent carboxylation of acetyl-CoA to malonyl-CoA, a critical step in fatty acid biosynthesis .
Target Protein: Biotin carboxylase subunit (encoded by the CAC2 gene) .
Molecular Weight: Recognizes a 51 kDa polypeptide in Arabidopsis extracts .
Specificity: Reacts exclusively with the CAC2 subunit; preabsorption with the immunizing antigen abolishes reactivity .
Functional Inhibition: Inhibits ACCase enzymatic activity in vitro, confirming its specificity .
CAC2 is essential for fatty acid biosynthesis in plants. The antibody has been used to:
Study light-/dark-regulated ACCase activity in chloroplasts .
Investigate tissue-specific expression patterns, with highest activity in organs synthesizing membrane lipids or oils (e.g., seeds, flowers) .
CAC2 expression mirrors that of CAC1 (encoding the biotin carboxyl carrier subunit), suggesting transcriptional coordination .
Promoter analysis reveals shared regulatory motifs between CAC1 and CAC2, potentially governing co-expression .
Property | Detail |
---|---|
Target Species | Arabidopsis thaliana |
Immunogen | Glutathione S-transferase-CAC2 fusion protein |
Applications | Western blot, enzymatic inhibition assays |
Molecular Weight Detection | 51 kDa (native protein); 537 amino acids (precursor with transit peptide) |
Regulatory Role | pH-dependent activity modulation in chloroplasts |
Tissue | Expression Level | Functional Context |
---|---|---|
Seeds | High | Oil deposition |
Flowers | High | Membrane lipid synthesis |
Mature Leaves | Moderate | Baseline fatty acid production |
Roots | Low | Limited metabolic demand for fatty acids |
Metabolic Regulation: CAC2-mediated ACCase activity is critical for balancing fatty acid synthesis under varying light conditions .
Biotechnological Potential: Insights from CAC2 studies inform genetic engineering of oilseed crops to enhance lipid yields .
Current research is limited to model plants (A. thaliana); applicability in crops requires validation.
Further studies could explore CAC2’s interaction with other ACCase subunits and metabolic regulators.
Generating a collection of FAQs for "CAC2 Antibody" research requires synthesizing antibody development methodologies and experimental design principles from available academic sources. Below is a structured framework based on antibody research best practices and technical considerations from multispecific antibody development literature , combined with intent-driven question design strategies from search behavior analysis .
Methodological answer:
Perform blocking peptide assays by pre-incubating the antibody with excess target peptide to confirm signal loss.
Use genetic knockout controls (e.g., CRISPR/Cas9-modified cell lines lacking CAC2) to validate target binding .
Cross-validate with orthogonal techniques like Western blotting or SPR (surface plasmon resonance) to assess binding kinetics.
Validation Step | Purpose | Acceptance Criteria |
---|---|---|
Peptide Blocking | Confirm epitope specificity | ≥80% signal reduction |
Knockout Control | Rule off-target binding | No detectable signal |
Cross-reactivity Screen | Assess family protein binding | ≤5% cross-reactivity |
Resolution framework:
Buffer optimization: Adjust detergent concentrations (e.g., Triton X-100) to expose epitopes in flow cytometry .
Conformational analysis: Use circular dichroism to determine if fixation alters CAC2’s tertiary structure.
Epitope mapping: Employ hydrogen-deuterium exchange mass spectrometry to identify antibody binding regions affected by assay conditions.
Technical recommendations:
Optimize antibody clonality: Use rabbit monoclonal antibodies (e.g., clone RB-9214-P0) for higher affinity (KD ≤ 1 nM) .
Implement signal amplification systems: Tyramide-based amplification for low-abundance targets.
Validate with reference datasets: Compare results against single-cell RNA sequencing profiles of CAC2-expressing tissues.
Parameter | Requirement | Tool/Resource |
---|---|---|
Affinity | KD ≤ 1 nM | BioLayer Interferometry |
Multiplex Compatibility | No cross-talk with ≥5-plex panels | CODEX® validation |
Batch Consistency | CV ≤ 15% across lots | ISO 13485 standards |
Analytical approach:
Contextual metadata analysis: Compare cell lines/tissue sources used in conflicting studies (e.g., neoplastic vs. normal samples).
Post-translational modification screening: Test for phosphorylation-dependent epitope masking using λ-phosphatase treatment.
Single-molecule localization microscopy: Resolve ≤40 nm localization precision using dSTORM or PALM techniques .
Research Stage | Key Challenge | Recommended Protocol | Validation Metrics |
---|---|---|---|
Target Validation | Off-target binding | CRISPR knockout + MS/MS proteomics | ≥10-fold signal reduction |
Assay Development | Epitope accessibility | Antigen retrieval optimization (pH 9.0 citrate buffer) | CV ≤ 20% across runs |
Data Interpretation | Context-dependent variability | Integrated omics correlation analysis | R² ≥ 0.7 vs. transcriptomics |